Simon Imhof
Research:
Throughout the years of research conducted into Type I diabetes (T1D), it has been largely considered an immune system based disease, in which beta cells in the islets of Langerhans are destroyed and thus insulin production is impeded. However in the last years the focus has started from the role of the immune system to the beta cells themselves being an active part in the cascade leading to their destruction. In my research I am looking into multiple possibilities of how beta cells themselves contribute to being recognized and killed by autoreactive T-cells and options to hopefully intervene. Herein I investigate the role of surface glycans and their effect on the accessibility of human leukocyte antigens (HLA), how extracellular vesicles shape the environment and expression patterns of the cells as well as what effect immune response genes can have on the immunogenicity of them.
CV:
Throughout my studies, including my Bachelor in biology and my Master in molecular and cell biology, I was at the Ludwig-Maximilians Universität in Munich during which time I got to focus further into my interests in genetics, molecular biology and more specifically the mechanisms of transcriptional regulation. For most of this time I was also a working student in the Lab of Prof. Stefan Stricker at Helmholtz Munich where I was able to conduct research into the links between transcription and metabolism, help in tech development of new CRISPR based approaches for transcriptional modulation and look into the effects of non-coding RNAs in the context of cell identity. Now I started as a PhD student in the Lab of Arnaud Zaldumbide at the CCB working on Type I diabetes.